Ángela Molina-Crespo

发表

Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer

J. Serra-Musach, M. Pujana, P. Nuciforo, 2016, Oncotarget.

Gasdermin B over-expression arbitrates HER2-targeted therapy resistance by inducing protective autophagy

R. Rodríguez-Barrueco, J. Arribas, G. Moreno-Bueno, 2021, bioRxiv.

Running title : Different role of Gasdermin B isoforms in pyroptosis . 4 5

F. Rojo, J. Albanell, A. Lluch, 2022 .

Intracellular Delivery of an Antibody Targeting Gasdermin-B Reduces HER2 Breast Cancer Aggressiveness

O. Herzberg, G. Moreno-Bueno, M. Garcia‐Fuentes, 2019, Clinical Cancer Research.

Gasdermin B over-expression modulates HER2-targeted therapy resistance by inducing protective autophagy through Rab7 activation

R. Rodríguez-Barrueco, J. Arribas, G. Moreno-Bueno, 2022, Journal of Experimental & Clinical Cancer Research.

Gasdermin-B Promotes Invasion and Metastasis in Breast Cancer Cells

D. Megías, G. Moreno-Bueno, P. García-Sanz, 2014, PloS one.

The multifaceted roles of gasdermins in cancer biology and oncologic therapies.

G. Moreno-Bueno, L. Sánchez, D. Sarrió, 2021, Biochimica et biophysica acta. Reviews on cancer.

Exosome-mimetic nanoplatforms for targeted cancer drug delivery

Abi J. Vázquez-Ríos, Ángela Molina-Crespo, Belén L. Bouzo, 2019, Journal of Nanobiotechnology.

Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and mitochondrial damage in cancer cells

F. Rojo, J. Albanell, A. Lluch, 2022, bioRxiv.

Intracellular Delivery of an Antibody Targeting Gasdermin-B Reduces HER2 Breast Cancer Aggressiveness

O. Herzberg, G. Moreno-Bueno, M. Garcia‐Fuentes, 2019, Clinical Cancer Research.